Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Alzamend Neuro, Inc. (ALZN) had Free Cash Flow of $-1.14M for the most recently reported fiscal quarter, ending 2026-07-31.
| Income Statement Financials | |
-- |
|
$-3.03M |
|
-- |
|
-- |
|
$3.03M |
|
$-3.03M |
|
$-0.00M |
|
$-3.03M |
|
$-3.03M |
|
$-3.03M |
|
$-3.03M |
|
$-3.03M |
|
$-3.03M |
|
$-3.03M |
|
$-3.00M |
|
4.48M |
|
4.48M |
|
$-0.68 |
|
$-0.68 |
|
| Balance Sheet Financials | |
$8.25M |
|
$0.29M |
|
$0.29M |
|
$8.54M |
|
$2.74M |
|
-- |
|
-- |
|
$2.74M |
|
$5.80M |
|
$5.80M |
|
$5.80M |
|
4.83M |
|
| Cash Flow Statement Financials | |
$-1.14M |
|
-- |
|
$8.02M |
|
$0.71M |
|
$7.59M |
|
$6.88M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-1.14M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-52.17% |
|
-52.17% |
|
-35.44% |
|
-52.17% |
|
$1.20 |
|
$-0.25 |
|
$-0.25 |
|